GLYC GlycoMimetics, Inc.
GLYC was the NASDAQ ticker symbol of GlycoMimetics, Inc. It no longer appears in current US listing files, which usually means the security was delisted, acquired, merged, or moved to a new symbol. SEC records list “Glycomimetics Inc” as a former name of Crescent Biopharma, Inc., which trades today as CBIO.
GLYC at a glance
- Symbol
- GLYC
- Company / issuer
- GlycoMimetics, Inc.
- Security type
- Common stock
- Last exchange
- NASDAQ
- Status
- No longer listed
- Seen in listing files
- Jan 2015 – Jun 2025
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Country
- United States
- IPO year
- 2014
- Last reported market cap
- $13.5 million (May 2025)
GLYC ticker history
All listing names we have recorded under the symbol GLYC, from periodic snapshots of US exchange listing files.
| Name | Security | First seen | Last seen |
|---|---|---|---|
| GlycoMimetics, Inc. | Common Stock | Jan 2015 | Jun 2025 |
Snapshots have gaps (notably 2018–2021, and 2015–2021 for NYSE listings), so the actual delisting date may be later than the last-seen date.
Frequently asked questions
What company has the ticker symbol GLYC?
GLYC was the ticker symbol of GlycoMimetics, Inc on NASDAQ.
Is GLYC still trading?
No. GLYC does not appear in current US exchange listings as of Sep 2026; it was last seen in our listing snapshots in Jun 2025. The company now appears to trade as CBIO (Crescent Biopharma, Inc.).
Which exchange was GLYC listed on?
GLYC was listed on NASDAQ.